Dr Reddy's Labs launches copy of BI drug; move may lead to legal battle

Under its brand Vicra, Dr. Reddy's is expected to sell the drug in India at less than a third of the price charged by Boehringer Ingelheim. According to sources the 10 mg variant of Dr. Reddy's brand may cost ₹15 per tablet against ₹51 of the innovator's brand.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3n5MRWC
via IFTTT